Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2002 2
2003 1
2004 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma.
Geschwind JF, Georgiades CS, Ko YH, Pedersen PL. Geschwind JF, et al. Expert Rev Anticancer Ther. 2004 Jun;4(3):449-57. doi: 10.1586/14737140.4.3.449. Expert Rev Anticancer Ther. 2004. PMID: 15161443 Review.
Mitochondrial events in the life and death of animal cells: a brief overview.
Pedersen PL. Pedersen PL. J Bioenerg Biomembr. 1999 Aug;31(4):291-304. doi: 10.1023/a:1005453700533. J Bioenerg Biomembr. 1999. PMID: 10665520 Review.
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.
Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL. Ko YH, et al. Biochem Biophys Res Commun. 2004 Nov 5;324(1):269-75. doi: 10.1016/j.bbrc.2004.09.047. Biochem Biophys Res Commun. 2004. PMID: 15465013
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL. Geschwind JF, et al. Cancer Res. 2002 Jul 15;62(14):3909-13. Cancer Res. 2002. PMID: 12124317 Free article.
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.
Ko YH, Pedersen PL, Geschwind JF. Ko YH, et al. Cancer Lett. 2001 Nov 8;173(1):83-91. doi: 10.1016/s0304-3835(01)00667-x. Cancer Lett. 2001. PMID: 11578813
Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.
Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH. Pedersen PL, et al. Biochim Biophys Acta. 2002 Sep 10;1555(1-3):14-20. doi: 10.1016/s0005-2728(02)00248-7. Biochim Biophys Acta. 2002. PMID: 12206885 Free article.
Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression.
Goel A, Mathupala SP, Pedersen PL. Goel A, et al. J Biol Chem. 2003 Apr 25;278(17):15333-40. doi: 10.1074/jbc.M300608200. Epub 2003 Feb 3. J Biol Chem. 2003. PMID: 12566445 Free article.
Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions.
Mathupala SP, Rempel A, Pedersen PL. Mathupala SP, et al. J Biol Chem. 2001 Nov 16;276(46):43407-12. doi: 10.1074/jbc.M108181200. Epub 2001 Sep 13. J Biol Chem. 2001. PMID: 11557773 Free article.